News ASH: Stem cell transplant study exposes US zip-code lottery Access to a stem cell transplant in the US - and the chances of surviving it - depends on social and economic factors, finds a new study.
Partner Content Partner Content COUCH Health Finds Reasons Behind Underrepresentation of Min... New research shows how to improve trial diversity
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.